Immucell Corp /De/ financial data

Symbol
ICCC on Nasdaq
Location
56 Evergreen Dr, Portland, ME
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 388 % +42.3%
Quick Ratio 195 % +14%
Debt-to-equity 57.7 % -22.1%
Return On Equity 8 %
Return On Assets 5.07 %
Operating Margin 6.13 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.05M shares +1.51%
Common Stock, Shares, Outstanding 9.05M shares +2.41%
Entity Public Float 30.6M USD -1.7%
Common Stock, Value, Issued 911K USD +2.35%
Weighted Average Number of Shares Outstanding, Basic 9.05M shares +10.8%
Weighted Average Number of Shares Outstanding, Diluted 9.05M shares +10.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 28.3M USD +17.8%
Revenue from Contract with Customer, Excluding Assessed Tax 5.51M USD -8.41%
Cost of Revenue 3.14M USD -29%
Research and Development Expense 3.1M USD -25.2%
Selling and Marketing Expense 3.31M USD +0.2%
General and Administrative Expense 2.63M USD +20.2%
Operating Income (Loss) 2.33M USD
Nonoperating Income (Expense) 9.32K USD -23.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.34M USD +80.7%
Income Tax Expense (Benefit) 14.3K USD +166%
Net Income (Loss) Attributable to Parent 2.32M USD +80.1%
Earnings Per Share, Basic 0 USD/shares +77.8%
Earnings Per Share, Diluted 0 USD/shares +77.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.89M USD
Accounts Receivable, after Allowance for Credit Loss, Current 2.55M USD +10.7%
Inventory, Net 9.8M USD +31.4%
Other Assets, Current 57.7K USD -24.8%
Assets, Current 16.8M USD +21.2%
Property, Plant and Equipment, Net 24.3M USD -5.73%
Operating Lease, Right-of-Use Asset 4.42M USD -3.77%
Intangible Assets, Net (Excluding Goodwill) 43K USD -30.8%
Goodwill 95.6K USD 0%
Other Assets, Noncurrent 44.3K USD +53.4%
Assets 45.7M USD +2.88%
Liabilities, Current 4M USD -10.5%
Long-term Debt and Lease Obligation 8.65M USD -14.9%
Operating Lease, Liability, Noncurrent 4.03M USD -2.79%
Liabilities 15.9M USD -11.7%
Retained Earnings (Accumulated Deficit) -12.4M USD +15.8%
Stockholders' Equity Attributable to Parent 29.8M USD +12.8%
Liabilities and Equity 45.7M USD +2.88%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.57M USD +276%
Net Cash Provided by (Used in) Financing Activities -404K USD -10.1%
Net Cash Provided by (Used in) Investing Activities -329K USD -368%
Common Stock, Shares Authorized 15M shares 0%
Common Stock, Shares, Issued 9.11M shares +2.35%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6M USD +353%
Interest Paid, Excluding Capitalized Interest, Operating Activities 118K USD -13.6%
Deferred Tax Assets, Valuation Allowance 4.59M USD +13.9%
Operating Lease, Liability 4.12M USD -11.1%
Depreciation 2.68M USD +0.33%
Payments to Acquire Property, Plant, and Equipment 329K USD +368%
Lessee, Operating Lease, Liability, to be Paid 7.05M USD -10.5%
Property, Plant and Equipment, Gross 45.9M USD -0.57%
Operating Lease, Liability, Current 82.4K USD -82.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 354K USD +1.16%
Lessee, Operating Lease, Liability, to be Paid, Year One 347K USD -51.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.93M USD -9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 361K USD +1.16%
Deferred Tax Assets, Operating Loss Carryforwards 3.71M USD -0.63%
Current Income Tax Expense (Benefit) 8.43K USD -26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 368K USD +1.24%
Operating Lease, Payments 748K USD +35.9%
Additional Paid in Capital 36.2M USD +0.9%
Amortization of Intangible Assets 19.1K USD 0%
Depreciation, Depletion and Amortization 709K USD +3.32%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 261K USD -27%
Interest Expense 585K USD +40.3%